BackZhengye Biotechnology Holding Limited Overview

Zhengye Biotechnology Holding Limited Other Current Liabilities

Track Zhengye Biotechnology Holding Limited's other current liabilities ($3.4M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$3.39M
39.10% YoYΔ $-2.17M vs prior year quarter

Peer trimmed avg / median

Loading

Zhengye Biotechnology Holding Limited Other Current Liabilities History

Loading

Zhengye Biotechnology Holding Limited vs. peers: Other Current Liabilities Comparison

Loading

Zhengye Biotechnology Holding Limited Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Zhengye Biotechnology Holding Limited (ZYBT) FAQ

Zhengye Biotechnology Holding Limited's other current liabilities stands at $3.4M as of December 2025. That compares with $5.6M in the prior-year period — down 39.1% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Zhengye Biotechnology Holding Limited reported $3.4M in other current liabilities versus $5.6M a year earlier — a 39.1% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $5.6M in the prior-year period — down 39.1% year over year. Sustained growth in other current liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Zhengye Biotechnology Holding Limited's other current liabilities evolved across reporting periods, while the comparison chart places ZYBT next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.